Steinkampf MP

No ORCID on file · 10 papers in corpus
observational 2021
Sexually transmitted diseases ·doi:10.1097/olq.0000000000001434

BACKGROUND: Chlamydial infection is associated with tubal factor infertility (TFI); however, assessment of prior chlamydial infection and TFI is imperfect. We previously evaluated a combination of serological assays for association with TFI…

observational 2021
Sexually transmitted diseases ·doi:10.1097/olq.0000000000001435

BACKGROUND: Nearly 14% of US women report any lifetime infertility which is associated with health care costs and psychosocial consequences. Tubal factor infertility (TFI) often occurs as a result of sexually transmitted diseases and subseq…

observational 2017
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2017.05.026

BACKGROUND: Chlamydia trachomatis infection is highly prevalent among young women in the United States. Prevention of long-term sequelae of infection, including tubal factor infertility, is a primary goal of chlamydia screening and treatmen…

observational 2012
Human reproduction (Oxford, England) ·doi:10.1093/humrep/der436

BACKGROUND: Although histological dating of endometrial biopsies provides little help for prediction or diagnosis of infertility, analysis of individual endometrial proteins, proteomic profiling and transcriptome analysis have suggested sev…

observational 2006
Fertility and sterility ·doi:10.1016/j.fertnstert.2006.06.050

We investigated the prevalence of abnormal screening results (questionnaire and testing for other causes of oligo-ovulation, male or tubal factor infertility) in a group of 1,313 oligo-ovulatory women (included and excluded subjects) whose …

rct 2003
Fertility and sterility ·doi:10.1016/s0015-0282(03)02166-6

OBJECTIVE: The purpose of this study was to prospectively compare the effectiveness of administering medroxyprogesterone acetate (MPA; 20 mg/d) in either the first (protocol A) or last (protocol B) 12-week period as well as a 6-month course…

rct 2003
Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-1-63

BACKGROUND: These data compare the efficacy and safety of highly purified human-derived follicle-stimulating hormone (Bravelle) and recombinant follitropin-beta (Follistim) in women undergoing in vitro fertilization. METHODS: This report d…

observational 2003
Fertility and sterility ·doi:10.1016/j.fertnstert.2003.05.012

OBJECTIVE: To assess the value of laparoscopic evaluation of the pelvis after failure to achieve pregnancy with clomiphene citrate-induced ovulation and to determine whether predictors for significant pelvic pathology can be isolated. DESI…

other 1998
Fertility and sterility ·doi:10.1016/s0015-0282(98)00177-0

OBJECTIVE: To analyze the efficacy and cost-effectiveness of alternative treatments for unexplained infertility. DESIGN: Retrospective analysis of 45 published reports. SETTING: Clinical practices. PATIENT(S): Couples who met criteria fo…

other 1995
Fertility and sterility ·doi:10.1016/s0015-0282(16)57695-x